PEAK Stock Recent News

HMS Networks AB (publ) (“HMS”), a global provider of industrial information and communication technology, has today entered into a binding agreement with DOGAWIST-Investment GmbH to acquire 100% of the shares in PEAK-System Technik GmbH (“PEAK-System”), a well-established German provider of industrial communication solutions.

The margin of safety, introduced by Benjamin Graham, emphasizes diversification to protect against volatility and human errors, enhancing the probability of profitable outcomes. Healthpeak Properties, Plymouth Industrial REIT, and Realty Income are highlighted as REITs with a significant margin of safety, each rated as a Buy. Healthpeak Properties benefits from a merger, strong earnings, and a diversified healthcare portfolio, trading at a discount with a 5.45% dividend yield.

High demand for lab assets and rising senior citizens' healthcare spending are likely to support DOC's performance.

Healthpeak Properties is a leading U.S. real estate investment trust focused on medical office buildings, poised for long-term growth. The merger with Physician Realty Trust has increased the trust's portfolio to 748 properties, with potential for $80 million in synergies. With a steady dividend and strong funds from operations growth, Healthpeak Properties is a compelling investment for passive income investors.

AUSTIN, Texas , June 3, 2024 /PRNewswire/ -- An affiliate of Peak Rock Capital ("Peak Rock"), a leading middle-market private equity firm, announced today that it has completed the previously announced acquisition of the dental segment ("HuFriedyGroup" or the "Company") of STERIS plc (NYSE:STE) ("STERIS"). Founded in 1908, HuFriedyGroup is a leading global manufacturer of high-quality instruments, infection prevention products, instrument management systems, and conscious sedation products for the dental industry.

WALTHAM, Mass. and BOULDER, Colo., May 23, 2024 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc.  (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced positive updated lead-in data from the company's ongoing Phase 3 PEAK trial evaluating the selective and potent KIT mutant inhibitor, bezuclastinib, in combination with sunitinib, in patients with Gastrointestinal Stromal Tumors (GIST). The data will be presented in a poster presentation at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, IL on June 1. Cogent also announced today a new Phase 2 clinical trial of bezuclastinib plus sunitinib in later line GIST patients, sponsored by the Sarcoma Alliance for Research through Collaboration (SARC) and in collaboration with The Life Raft Group and Dana-Farber Cancer Institute.

“Higher for longer” may prove true as sticky inflation indicates the higher-rate environment might be here to stay. As interest rates stay steady, risk-averse investors gravitate towards short-term Treasuries for safety.

Healthpeak (PEAK) closes its merger with Physicians Realty Trust, positioning it well to capitalize on the secular trends of the industry.

DENVER--(BUSINESS WIRE)--Healthpeak Properties, Inc. (NYSE: PEAK), a leading owner, operator, and developer of real estate for healthcare discovery and delivery, announced today that Scott Brinker, its President and Chief Executive Officer, is scheduled to present at the Citi 2024 Global Property CEO Conference. The presentation is scheduled for 11:40 a.m. Eastern Time on Tuesday, March 5, 2024. You can access the webcast by visiting our website at https://ir.healthpeak.com/news-events/default.

Healthpeak Properties: Undervalued With Strong Fundamentals